Thomas H Oguin Selected Research

VU0468809

12/2014

Discovery of a highly selective PLD2 inhibitor (ML395): a new probe with improved physiochemical properties and broad-spectrum antiviral activity against influenza strains.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas H Oguin Research Topics

Disease

7	Infections 02/2022 - 12/2010
4	COVID-19 02/2021 - 10/2020
4	Human Influenza (Influenza) 12/2014 - 12/2010
2	Edema (Dropsy) 02/2021 - 01/2021
2	Virus Diseases (Viral Diseases) 02/2021 - 01/2021
2	Pneumonia (Pneumonitis) 02/2021 - 01/2021
1	Primary Immunodeficiency Diseases 01/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 03/2013

Drug/Important Bio-Agent (IBA)

4	Neutralizing AntibodiesIBA 02/2022 - 10/2020
3	VaccinesIBA 02/2022 - 10/2020
3	AntibodiesIBA 02/2021 - 10/2020
2	Blocking AntibodiesIBA 02/2021 - 01/2021
2	CytokinesIBA 02/2021 - 01/2021
2	Fc Receptors (Fc Receptor)IBA 02/2021 - 01/2021
2	1-dodecylpyridoxal (PLD)IBA 12/2014 - 09/2014
1	sortase AIBA 02/2022
1	Ferritins (Ferritin)IBA 02/2022
1	GlobulinsIBA 01/2021
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2021
1	Messenger RNA (mRNA)IBA 10/2020
1	NucleosidesIBA 10/2020
1	mRNA VaccinesIBA 10/2020
1	VU0468809IBA 12/2014
1	Antiviral Agents (Antivirals)IBA 12/2014
1	Phospholipase DIBA 09/2014
1	AntigensIBA 02/2014
1	ML299IBA 03/2013
1	3,4- difluoro- N- (2- (1- (3- fluorophenyl)- 4- oxo- 1,3,8- triazaspiro(4.5)decan- 8- yl)ethyl)benzamideIBA 03/2013
1	decaneIBA 03/2013
1	EpitopesIBA 01/2011
1	Inactivated VaccinesIBA 12/2010
1	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2010